Explorer les evidences

10 %Among 436 treatment-naïve Nigerian breast cancer patients, 10% were classified as having high tumor-infiltrating lymphocytes (TILs) (≥40%).

Nigeriacancer du seinpublié 2026Breast cancer research and treatmentPubMeddocument de 14 observations

27 participantsTwenty-seven out of 46 participants (58.6%) had a diagnostic interval within 60 days.

Nigeriacancer du seinpublié 2025BMC cancerPubMeddocument de 11 observations

3,9 %Nigerian breast cancer patients have a BRCA2 mutation frequency of 3.9%.

Nigeriacancer du seinpublié 2012International journal of cancereurope_pmcdocument de 2 observations

33 %Of those who did not receive surgery, the most common reason was cost (n = 41/125, 33%).

Nigeriacancer du seinpublié 2026Psycho-oncologyPubMeddocument de 11 observations

5 192,77 USDThe mean cost of care was $5192.77 (SD $4567.71).

Nigeriacancer du seinpublié 2024Journal of cancer policyPubMeddocument de 4 observations

100 %Among 130 breast cancer patients who underwent multiple treatment modalities, 100% risked financial catastrophe.

Nigeriacancer du seinpublié 2025American journal of surgeryPubMeddocument de 13 observations

90,3 %The majority, 316 (90.3%) of the 350 female undergraduates, had poor knowledge of breast cancer and screening.

Nigeriacancer du seinpublié 2022African health sciencesPubMeddocument de 5 observations

6,7 %Pathogenic BRCA1/2 variants were identified in 6.7% of breast cancer patients.

Nigeriacancer du seinpublié 2025Technology in cancer research & treatmentPubMeddocument de 2 observations

26,6 %25 out of 94 women with breast cancer perceived treatment of discomfort as the main benefit of exercise, representing 26.6%.

Nigeriacancer du seinpublié 2021Breast diseasePubMeddocument de 4 observations

40 %Among 607 patients diagnosed with breast cancer in Nigeria between January 2010 and December 2018, 40% were estrogen receptor positive.

Nigeriacancer du seinobservé 2010–2018publié 2021International journal of cancerPubMeddocument de 12 observations

54,93 %54.93% of the respondents had good knowledge of breast self-examination.

Nigeriacancer du seinpublié 2023BMC women's healthPubMeddocument de 12 observations

72 %Seventy-two percent of households had to borrow money as a result of accessing breast cancer treatment.

Nigeriacancer du seinpublié 2022The Pan African medical journalPubMeddocument de 9 observations

44 %One hundred patients (44%) underwent mastectomy, 97 within 1 year of diagnosis.

Nigeriacancer du seinpublié 2026Psycho-oncologyPubMeddocument de 11 observations

10,1 %A hybrid breast cancer genetics education program for Nigerian health care providers resulted in a further 10.1% gain in knowledge after the in-person workshop.

Nigeriacancer du seinpublié 2026JCO global oncologyPubMeddocument de 5 observations

15,7 %The proportion of metastatic breast cancer cases was 15.7% during 2016–2018.

Nigeriacancer du seinobservé 2016-2018publié 2023West African journal of medicinePubMeddocument de 8 observations

30,6 %30.6% of the respondents had average knowledge of the risk factors and symptoms of breast cancer.

Nigeriacancer du seinpublié 2024West African journal of medicinePubMeddocument de 7 observations

On multivariate analysis, D-dimer and fibrinogen were independently related to lymph node involvement in breast cancer patients.

Nigeriacancer du seinpublié 2021Cancer investigationPubMeddocument de 4 observations

55,6 %Among 6,274 participants, 55.6% (3,478) were breast cancer cases.

Nigeriacancer du seinpublié 2024Cancer causes & control : CCCPubMeddocument de 5 observations

20,09 %Middle-aged individuals had 20.09% knowledge about red meat/smoked foods as a breast cancer risk factor.

Nigeriacancer du seinpublié 2024JCO global oncologyPubMeddocument de 12 observations

45,97 %Among 3,263 breast histopathology records reviewed from 2015 to 2023, most breast cancer cases were in young adults (20–39 years) at 45.97%.

Nigeriacancer du seinobservé 2015 to 2023publié 2025Scientific reportsPubMeddocument de 12 observations

5 %Among cases, 5.0% (50 individuals) were classified as high risk using a lifetime absolute risk threshold of 10% or higher in the PRS plus PV model.

Nigeriacancer du seinpublié 2025JAMA network openPubMeddocument de 6 observations

44,41 %The right breast had a malignancy rate of 44.41% among the 3,263 breast histopathology records.

Nigeriacancer du seinobservé 2015 to 2023publié 2025Scientific reportsPubMeddocument de 12 observations

D-dimer and fibrinogen were significantly positively correlated with ECOG, disease stage, lymph node involvement, and tumor size in breast cancer patients.

Nigeriacancer du seinpublié 2021Cancer investigationPubMeddocument de 4 observations

46,5 %46.5% of breast cancer patients underwent surgery.

Nigeriacancer du seinobservé May 2009–January 2019publié 2021CancerPubMeddocument de 7 observations

21 participantsTwenty-one out of 46 participants (46%) recognized family history as a risk factor for breast cancer.

Nigeriacancer du seinpublié 2025BMC cancerPubMeddocument de 11 observations